Fundamental Technologies for Development of Biomolecular Sensors.Based upon a shared vision of the future of human health care, the National Aeronautics and Space Administration National Aeronautics and Space Administration (NASA), civilian agency of the U.S. federal government with the mission of conducting research and developing operational programs in the areas of space exploration, artificial satellites (see satellite, artificial), (NASA NASA: see National Aeronautics and Space Administration. NASA in full National Aeronautics and Space Administration Independent U.S. ) and the National Cancer Institute (NCI See Liberate. ) are forming a partnership to jointly research and develop biomolecular sensors that will revolutionize rev·o·lu·tion·ize tr.v. rev·o·lu·tion·ized, rev·o·lu·tion·iz·ing, rev·o·lu·tion·iz·es 1. To bring about a radical change in: Television has revolutionized news coverage. 2. the practice of medicine on earth and in space. Specifically, NASA and the NCI recognize mutual objectives in advancing the development of technologies and informatics Same as information technology and information systems. The term is more widely used in Europe. tools to enable minimally invasive detection, diagnosis, and management of disease and injury through the support of fundamental technology development. NASA and the NCI are specifically interested in supporting the development of new technologies to scan the body for the earliest signs of emerging disease and support immediate, specific intervention. The ability to scan the body for early signs requires that these technologies to be minimally invasive. To prevent the rapid expansion of disease and maximize the benefit of the earliest detection, future technologies should support a seamless interface between detection, diagnosis, and intervention. The detection, diagnosis, and intervention will be based on the capacity to measure, analyze, and manipulate molecular processes at an appropriate scale in the living body. Essential to the utility of these technologies is the development of information infrastructure and analysis tools that will link the information on basic discoveries, intervention discoveries, and clinical outcome information to specific patient histories to aid the caregiver in making rapid, informed decisions about appropriate intervention. Specific areas for fundamental technology development targeted by this solicitation solicitation In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual include 1) novel molecular recognition chemistries, materials, chemical composites, nanoparticles, nanostructures, agents, and devices suitable for in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body. in vi·vo adj. Within a living organism. in vivo adv. use; 2) novel strategies for in vivo signal generation and amplification; 3) systems suitable for noninvasive, dynamic signal acquisition from deep tissues and systems of reduced scale suitable for manned space missions; 4) new tools for feature definition and extraction, including computational and mathematical approaches; and 5) new approaches and multifunctional technology platforms to create an interface between in vivo detection and targeted intervention, including nanostructures/devices and novel materials and composites. It is anticipated that multiple awards will result from this announcement. The length of time for which funding is requested should be consistent with the nature and complexity of the proposed research. The maximum period acceptable for a research proposal is three years. Awards are expected to be made in or around December 2001. The average total annual cost (including both direct and indirect costs Indirect costs are costs that are not directly accountable to a particular function or product; these are fixed costs. Indirect costs include taxes, administration, personnel and security costs. See also
Full details of this solicitation can be found on the Internet at http://rcb.nci.nih.gov/appl/rfp/17016/ Table%20of%20Contents.htm#INSTRUCT. Applications are due 30 April 2001. Contact: Richard L. Hartmann, Contracting Officer A US military officer or civilian employee who has a valid appointment as a contracting officer under the provisions of the Federal Acquisition Regulation. The individual has the authority to enter into and administer contracts and determinations as well as findings about such contracts. , Research Contracts and Acquisition Branch, NCI, Executive Plaza South, Room 603, 6120 Executive Boulevard, Rockville, MD 20852 USA, 301-496-8620, e-mail: rh75f@nih.gov. Reference: N01-CO-17016-32 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion